There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

The National Pharmacy Association is calling for tougher rules in the market, saying people with a history of eating ...

Nick Kaye, chairman of the NPA, told the PA news agency: “It is important that consultations with patients are thorough, ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...